Form EFFECT CRESCENT BIOPHARMA, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 3, 2026 |
| Accession Number: | 0001628280-26-013540 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crescent Biopharma Announces Grants of Inducement Awards
- Tiryaki Syria and Syrian Sovereign Fund Enter Cooperation to Strengthen Agricultural Industry
- CBAK Energy Showcases Cylindrical Battery Solutions for Europe’s Expanding Energy Storage Market at The Battery Show Europe 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
